Project Grant T32CA310878
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $537K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $395,494 Project Grant from the National Cancer Institute under the Cancer Research Manpower program (CFDA 93.398), awarded August 6, 2025, with completion targeted for July 31, 2029. The award funds the Improving Affordability in Cancer Care Through Economic Screening and Support (I-ACCESS) initiative, a screening assessment and referral program designed to proactively identify cancer-related financial...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $495,036 Project Grant awarded September 14, 2025, by the National Institute for Minority Health and Health Disparities under the Minority Health and Health Disparities Research program (CFDA 93.307) to support cervical cancer screening initiatives in rural North Carolina. The project, titled "Uniting Trusted Community Messengers to Improve Access to Cervical Cancer Screening in Rural North...
- Federal Grant Award Summary The National Cancer Institute awards $653,846 to the University of North Carolina at Chapel Hill under the Cancer Treatment Research program (CFDA 93.395) for a five-year project period (July 1, 2026 – June 30, 2031). This Project Grant supports the development of novel cancer therapeutics through targeted protein degradation (TPD), an emerging therapeutic strategy designed to move beyond traditional pharmacology by recruiting proteins of interest to cellular...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $399,829 Project Grant from the National Cancer Institute (National Institutes of Health) under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded May 15, 2026, with completion scheduled for April 30, 2028. This award supports the establishment of a population-based hepatocellular carcinoma (HCC) surveillance registry designed to improve early detection and risk stratification among...
- Federal Grant Award Summary The National Cancer Institute awarded $2,753,832 to the University of North Carolina at Chapel Hill under the Cancer Cause and Prevention Research program (CFDA 93.393) on September 15, 2025, for a five-year project concluding August 31, 2030. This Project Grant supports a Phase IIA randomized placebo-controlled trial investigating the safety, adherence, and preliminary efficacy of adjuvant 5-fluorouracil (5FU)—an affordable, patient-administered intravaginal...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded a $150,784 Project Grant under the Cancer Biology Research program (CFDA 93.396) to the University of North Carolina at Charlotte, effective September 1, 2025, through August 31, 2027. This two-year research initiative investigates the interplay between Heat Shock Protein 70 (HSP70) chaperone function and cyclin D1/CLN3 cell cycle regulation, with direct implications for cancer therapeutics. The research focuses on...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded $117,144 to the University of North Carolina at Chapel Hill under the Cancer Research Manpower program (CFDA 93.398) to support cancer research training and workforce development. The award, dated June 1, 2026, with completion by May 31, 2028, funds a K99/R00 career transition grant for Dr. Jessica Stewart to investigate how Epstein-Barr Virus (EBV) suppresses uracil DNA repair mechanisms in B-cell lymphomas,...
- Federal Project Grant Award Summary The University of North Carolina at Chapel Hill received a $207,802 Project Grant from the National Cancer Institute under the Cancer Detection and Diagnosis Research program (CFDA 93.394) awarded May 1, 2026, with completion scheduled for April 30, 2029. The grant funds development of multiplexed multiscale imaging technologies and automated microscopy systems to advance cellular immunotherapy research, specifically targeting improved understanding of...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded the University of North Carolina at Chapel Hill a Project Grant of $627,676 under the Cancer Biology Research program (CFDA 93.396) for the period September 1, 2025 through August 31, 2028. This three-year research initiative focuses on developing and validating genetically-encoded biosensors to characterize intercellular heterogeneity in cell cycle quiescence—specifically the spectrum of quiescent (dormant) states in cancer...
- Federal Grant Award Summary The National Cancer Institute awarded $628,539 to the University of North Carolina at Chapel Hill under the Cancer Treatment Research program (CFDA 93.395) for a five-year project running from July 1, 2026, through June 30, 2031. The research focuses on developing novel small-molecule inhibitors targeting the deubiquitinase enzyme OTUD7A as a therapeutic strategy for Ewing sarcoma, an aggressive pediatric and early-adult malignancy with significant treatment...